The use of corticosteroids for COVID-19 infection
Afr. j. med. med. sci
;
26(3): 1-3, 2020.
Artigo
em Inglês
| AIM
| ID: biblio-1257346
ABSTRACT
The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detrimental effects of corticosteroid therapy in general viral respiratory infections and, in particular, COVID-19 infections. While the definitive answer may need to await the results of ongoing randomised, controlled trials recent studies suggest that corticosteroid use in COVID-19 cases with hypoxaemia may benefit from low-dose corticosteroid therapy
Buscar no Google
Índice:
AIM (África)
Assunto principal:
África do Sul
/
Corticosteroides
/
Infecções por Coronavirus
/
Coronavírus Relacionado à Síndrome Respiratória Aguda Grave
/
COVID-19
Tipo de estudo:
Ensaio Clínico Controlado
/
Guia de Prática Clínica
País/Região como assunto:
África
Idioma:
Inglês
Revista:
Afr. j. med. med. sci
Ano de publicação:
2020
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS